Westside Investment Management, Inc. Lantern Pharma Inc. Transaction History
Westside Investment Management, Inc.
- $470 Billion
- Q3 2024
A detailed history of Westside Investment Management, Inc. transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 30,650 shares of LTRN stock, worth $93,176. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,650
Previous 11,500
166.52%
Holding current value
$93,176
Previous $53.7 Million
109.46%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding LTRN
# of Institutions
34Shares Held
1.31MCall Options Held
39.8KPut Options Held
6.1K-
Vanguard Group Inc Valley Forge, PA364KShares$1.11 Million0.0% of portfolio
-
Cm Management, LLC185KShares$562,4000.57% of portfolio
-
New Edge Advisors, LLC New Orleans, LA137KShares$417,5070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$265,8020.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny84KShares$255,3600.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $32.9M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...